Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these https://matteoltyc223349.arwebo.com/58674003/tirzepatide-a-promising-new-treatment-for-obesity